Literature DB >> 15342194

ICAM-1 upregulation in the spinal cords of PLSJL mice with experimental allergic encephalomyelitis is dependent upon TNF-alpha production triggered by the loss of blood-brain barrier integrity.

Gwen S Scott1, Rhonda B Kean, Marzena J Fabis, Tatiana Mikheeva, Christine M Brimer, Timothy W Phares, Sergei V Spitsin, D Craig Hooper.   

Abstract

Urate (UA) selectively scavenges peroxynitrite-dependent radicals and suppresses CNS inflammation through effects that are manifested at the blood-brain barrier (BBB). ICAM-1 upregulation in the spinal cord tissues of myelin basic protein (MBP) immunized mice is selectively inhibited by UA treatment. In contrast, the expression of ICAM-1 and other adhesion molecules by circulating cells is unchanged. Moreover, TNF-alpha expression in the CNS tissues of MBP-immunized mice is suppressed by UA treatment but TNF-alpha-induced ICAM-1 expression on neurovascular endothelial cells is not. Therefore the effect of UA on ICAM-1 upregulation in the CNS tissues is likely due to its known contribution to the maintenance of BBB integrity in MBP-immunized mice which in turn inhibits cell invasion into the CNS and prevents TNF-alpha production in CNS tissues. Copyright 2004 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342194     DOI: 10.1016/j.jneuroim.2004.05.011

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

1.  Uric acid protects against secondary damage after spinal cord injury.

Authors:  Gwen S Scott; Salvatore Cuzzocrea; Tiziana Genovese; Hilary Koprowski; D Craig Hooper
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

2.  Severe acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccine.

Authors:  Natalia Pogrebnyak; Maxim Golovkin; Vyacheslav Andrianov; Sergei Spitsin; Yuriy Smirnov; Richard Egolf; Hilary Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-14       Impact factor: 11.205

3.  Temporal and Spatial Dynamics of Astroglial Reaction and Immune Response in Cuprizone-Induced Demyelination.

Authors:  Jun An; Jun-Jun Yin; Yan He; Ruo-Xuan Sui; Qiang Miao; Qing Wang; Jie-Zhong Yu; Jing-Wen Yu; Fu-Dong Shi; Cun-Gen Ma; Bao-Guo Xiao
Journal:  Neurotox Res       Date:  2019-11-13       Impact factor: 3.911

4.  Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity.

Authors:  Marzena J Fabis; Timothy W Phares; Rhonda B Kean; Hilary Koprowski; D Craig Hooper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-30       Impact factor: 11.205

5.  Early blood-brain barrier permeability in cerebella of PLSJL mice immunized with myelin basic protein.

Authors:  Sergei Spitsin; Carla Portocarrero; Timothy W Phares; Rhonda B Kean; Christine M Brimer; Hilary Koprowski; D Craig Hooper
Journal:  J Neuroimmunol       Date:  2008-04-11       Impact factor: 3.478

6.  Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy.

Authors:  Paola Luzi; Ronnie M Abraham; Mohammad A Rafi; Mark Curtis; D Craig Hooper; David A Wenger
Journal:  Brain Res       Date:  2009-09-11       Impact factor: 3.252

7.  A comparative evaluation of the response to peroxynitrite by a brain endothelial cell line and control of the effects by drug targeting.

Authors:  Christopher Bolton; Elizabeth G Wood; Gwen S Scott; Roderick J Flower
Journal:  Cell Mol Neurobiol       Date:  2009-03-28       Impact factor: 5.046

8.  Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier.

Authors:  Anirban Roy; D Craig Hooper
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

9.  Glutamate-stimulated peroxynitrite production in a brain-derived endothelial cell line is dependent on N-methyl-D-aspartate (NMDA) receptor activation.

Authors:  G S Scott; S R Bowman; T Smith; R J Flower; C Bolton
Journal:  Biochem Pharmacol       Date:  2006-09-24       Impact factor: 5.858

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.